Jianjun Weng - Tianan Pharmaceutical CEO and Director
TNPH Stock | USD 0.01 0.00 0.00% |
CEO
Mr. Weng is Chief Executive Officer and a Director of Tianan Pharmaceutical Co since January 2003. Since 1995 Mr. Weng has also been the Chief Executive Officer of Xian Gelin Science and Technology Limited Company, a research and development firm. Between 1999 and 2002 Mr. Weng was the Chief Executive Officer of Xian Tianan Pharmaceutical Limited Company. since 2003.
Age | 65 |
Tenure | 21 years |
Phone | 86 29 8538 1587 |
Web | http://www.Xatazy.com |
Tianan Pharmaceutical Management Efficiency
The company has return on total asset (ROA) of 0.1801 % which means that it generated a profit of $0.1801 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.2512 %, meaning that it created $0.2512 on every $100 dollars invested by stockholders. Tianan Pharmaceutical's management efficiency ratios could be used to measure how well Tianan Pharmaceutical manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Found 4 records | CEO Age | ||
Geoffrey Gilmore | Worthington Steel | 52 | |
Richard Marabito | Olympic Steel | 60 | |
Donald McNeeley | Olympic Steel | 70 | |
Maxime Seche | Seche Environnement SA | 34 |
Management Performance
Return On Equity | 0.25 | |||
Return On Asset | 0.18 |
Tianan Pharmaceutical Leadership Team
Elected by the shareholders, the Tianan Pharmaceutical's board of directors comprises two types of representatives: Tianan Pharmaceutical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Tianan. The board's role is to monitor Tianan Pharmaceutical's management team and ensure that shareholders' interests are well served. Tianan Pharmaceutical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Tianan Pharmaceutical's outside directors are responsible for providing unbiased perspectives on the board's policies.
Deshun Li, Director | ||
Lie Wei, Chief Officer | ||
Jianjun Weng, CEO and Director | ||
Yanqing Wang, Director | ||
Peng Xi, Chief Marketing Officer | ||
Ning Jia, Director | ||
Renhua Wang, Secretary | ||
Mingqi Sun, Chief Quality Officer | ||
Zhiguo Ma, Director | ||
Hailiang Xue, Chief Production Officer | ||
Ping Ren, Director | ||
Andong Jia, Chief Admin. Officer | ||
Huachu Tang, Chief Investment Officer | ||
Wei Li, Chief Financial and Accounting Officer | ||
Jinming Gao, Director | ||
Hongwei Wang, Director |
Tianan Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Tianan Pharmaceutical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.25 | |||
Return On Asset | 0.18 | |||
Profit Margin | 0.30 % | |||
Operating Margin | 0.36 % | |||
Current Valuation | 979.64 K | |||
Price To Earning | 0.15 X | |||
Price To Book | 1.20 X | |||
Price To Sales | 1.62 X | |||
Revenue | 10.65 M | |||
Gross Profit | 7.3 M |
Currently Active Assets on Macroaxis
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tianan Pharmaceutical Co. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Complementary Tools for Tianan Pink Sheet analysis
When running Tianan Pharmaceutical's price analysis, check to measure Tianan Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tianan Pharmaceutical is operating at the current time. Most of Tianan Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Tianan Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tianan Pharmaceutical's price. Additionally, you may evaluate how the addition of Tianan Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |